Fleur targets 8,900 rooms by FY31 with ₹960 crore equity

Fleur Hotels Limited plans to expand from 5,476 operating rooms in H1 FY27 to more than 8,900 rooms by FY31, supported by five identified projects with about 1,084 rooms, a further pipeline of about 2,300 rooms and a ₹960 crore primary investment from Warburg Pincus. The plan is presented alongside Fleur’s proposed separate listing.

How will Fleur reach more than 8,900 rooms by FY31?

Fleur intends to reach more than 8,900 rooms by FY31 from a base of 5,476 rooms across 38 operating hotels in H1 FY27. Its disclosed bridge consists of about 1,084 rooms in five announced hotels and a separate pipeline of about 2,300 rooms. The presentation describes these additions as supporting expansion to 8,900-plus rooms.

The implied increase from the H1 FY27 operating base to the FY31 target is about 3,400 rooms. Fleur’s portfolio history starts with its first 49-room hotel in FY05, followed by 898 rooms added in FY06-10, 1,638 in FY11-15, 2,222 in FY16-20 and 669 in FY21-26. The presentation attributes the lower FY21-26 addition to limited development during COVID and balance-sheet constraints.

Fleur identifies three funding sources for growth: a ₹960 crore Warburg Pincus primary investment, internal accruals and debt-financing capacity. The presentation’s portfolio timeline states that Warburg Pincus invested in Fleur in May 2026. It does not disclose project-level costs or allocate the ₹960 crore across individual hotels.

Which projects make up Fleur’s announced room additions?

Fleur’s five announced projects total about 1,084 rooms and are led by the 610-room Aurika Nehru Place in Delhi. The other four are Aurika Shimla with 90 rooms, Aurika Shillong with 165 rooms, Aurika Varanasi with 47 rooms and Lemon Tree Premier Bandra in Mumbai with 172 rooms.

The stated opening schedule runs from FY27 to CY31, or calendar year 2031. Aurika Shimla is scheduled for FY27, Shillong for FY28, Varanasi for FY29 and Bandra for FY30, while Aurika Nehru Place is indicated for CY31. Fleur says final approvals for the Delhi project are pending from authorities and that it remains subject to modification.

Fleur says its broader pipeline covers core metro cities, leisure destinations and international markets where Indians travel. However, the presentation does not identify the hotels, locations or delivery dates within the roughly 2,300-room pipeline. The five announced assets are therefore the most detailed part of the planned FY31 expansion.

Where are Fleur’s current revenues and earnings generated?

Fleur derives 78% of revenue and 83% of earnings before interest, taxes, depreciation and amortisation, or EBITDA, from Mumbai, Hyderabad, Delhi, Bangalore, Gurgaon and Pune. Mumbai is the largest contributor, accounting for 27% of revenue and 34% of EBITDA; Hyderabad contributes 13% of revenue and 14% of EBITDA, while Delhi contributes 13% on both measures.

Mumbai’s EBITDA share exceeds its revenue share by 7 percentage points, whereas the rest of India represents 22% of revenue but 17% of EBITDA. Fleur’s presentation describes the six cities as markets with high barriers to entry and constrained supply, while its 38-hotel operating footprint extends across commercial and leisure locations beyond those cities.

The market data cited by Fleur show branded hotel-room supply in the top six cities growing 5.3% from FY25 to FY30, compared with 9.6% across India. Delhi has the lowest stated growth at 2.5%, followed by Pune at 3.2%, while Bangalore is highest among the six at 8.7%. These are industry-report figures included in the presentation, not Fleur forecasts.

What financial performance is Fleur presenting for the expansion plan?

Fleur reported total revenue of ₹1,333 crore in FY26, compared with ₹1,189 crore in FY25 and ₹810 crore in FY23. The presentation states an 18% compound annual growth rate from FY23 to FY26. Net EBITDA after management fees was ₹554 crore in FY26 including renovation expense, compared with ₹510 crore in FY25 and ₹359 crore in FY23.

The FY26 EBITDA margin including renovation expense was 41.6%, down from 42.8% in FY25 and 44.4% in FY23. Excluding renovation expense, Fleur reported FY26 EBITDA of ₹612 crore and a 46.0% margin, compared with ₹544 crore and 45.8% in FY25. The difference between the FY26 EBITDA measures was ₹58 crore.

Fleur’s current revenue mix is weighted towards upscale and upper-midscale brands. Aurika Hotels & Resorts and Lemon Tree Premier together contributed 58% of revenue and 67% of EBITDA, with Aurika accounting for 24% of revenue and 30% of EBITDA. Four of the five named projects are Aurika hotels, while the Bandra project is Lemon Tree Premier.

What approvals does Fleur need before an independent listing?

Fleur’s independent listing requires the composite scheme of arrangement to become effective, with an appointed date of 1 April 2026. The presentation says the scheme needs approvals from shareholders, creditors, stock exchanges, the Securities and Exchange Board of India, or SEBI, the National Company Law Tribunal, or NCLT, the Competition Commission of India, or CCI, and other regulatory authorities.

The January 2026 scheme announcement and April 2026 CCI approval are marked completed in the stated timeline. Stock-exchange review and SEBI’s no-objection are shown as in progress from September 2026, while NCLT approval, shareholder and creditor approvals, and filing with the Registrar of Companies remain pending. Fleur indicates a CY27 listing on the National Stock Exchange and BSE after shares are allotted to Lemon Tree Hotels shareholders.

The FY26 revenue and EBITDA figures are described as based on management accounts and on the scheme becoming effective. That qualification means the presentation depicts Fleur on a post-scheme basis, while the legal separation and listing are still conditional on the stated approvals. No fixed listing date within CY27 is provided.

Conclusion

Fleur’s disclosed growth case combines a 5,476-room H1 FY27 base, about 1,084 rooms in five named projects and a further pipeline of about 2,300 rooms to support an FY31 target above 8,900 rooms. The ₹960 crore primary investment, ₹1,333 crore FY26 revenue and concentration of 83% of EBITDA in six cities frame the asset platform’s stated expansion plan.

The next items to watch are progress on the scheme approvals and the intended CY27 listing, as well as delivery of the named projects. Aurika Nehru Place represents 610 of the 1,084 announced rooms, but its final approvals remain pending and the presentation says the project may be modified. Fleur has also not provided property-level timing or locations for the approximately 2,300-room additional pipeline.